External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

<ul><li>MURA is a micro-cap, speculative, pre-revenue, and non-compounder company that spun off from Alkermes</li><li>Despite a rough start, it is gaining attention and has a market cap of $74 million with $16/share in cash</li><li>Morgan Stanley projects a trading value range estimate of $32-$63/share based on potential sales from their lead pipeline candidate; company is funded with $275 million in cash until 2025</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

MURA is a micro-cap, speculative, pre-revenue, and non-compounder company that spun off from AlkermesDespite a rough start, it is gaining attention and has a market cap of $74 million with $16/share in cashMorgan Stanley projects a trading value range estimate of $32-$63/share based on potential sales from their lead pipeline candidate; company is funded with $275 million in cash until 2025This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Mural Oncology Plc (MURA) - Tuesday, Dec 26, 2023

United States

Mural Oncology Public Limited Company operates as a clinical-stage oncology company. The Company focuses on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. Mural Oncology serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Mural Oncology (MURA US)

Mural Oncology Plc (MURA) - Tuesday, Dec 26, 2023

MURA is a micro-cap, speculative, pre-revenue, and non-compounder company that spun off from Alkermes. Despite a rough start, it is gaining...

Value Investors Club

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)